tirzepatide osa Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards? Obesity and obstructive sleep apnoea:
Description
Find out why experts recommend reducing SSBs for reproductive health

Trim and Fill imputed three missing studies, shifting the effect size downward and highlighting a likely overestimation of treatment effects due to bias

Author contributions AA: conception and design of study, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising the manuscript critically for important intellectual content

For researchers working with tirzepatide from any source, proper refrigeration protocols are essential

PMCID: PMC9244335

The medication is not recommended for people with severe gastrointestinal disease such as gastroparesis
